<?xml version="1.0" encoding="UTF-8"?>
<p>Trypanosomiasis is a fatal disease caused by the genus 
 <italic>Trypanosoma</italic>, affecting humans and animals in many African countries [
 <xref rid="B1-molecules-25-03781" ref-type="bibr">1</xref>,
 <xref rid="B2-molecules-25-03781" ref-type="bibr">2</xref>,
 <xref rid="B3-molecules-25-03781" ref-type="bibr">3</xref>]. The protozoan parasites are transmitted by the bite of infected flies of the Tabanidae family [
 <xref rid="B4-molecules-25-03781" ref-type="bibr">4</xref>,
 <xref rid="B5-molecules-25-03781" ref-type="bibr">5</xref>]. The World Health Organization (WHO) estimates that over 70 million people in Sub-Saharan Africa are exposed to the risk of contracting this disease, which is deadly if left untreated [
 <xref rid="B6-molecules-25-03781" ref-type="bibr">6</xref>]. Treatment of this condition has been a challenge [
 <xref rid="B7-molecules-25-03781" ref-type="bibr">7</xref>], although the recent introduction of fexinidazole promises to alleviate some of the efficacy, toxicity and administration problems experienced with historical drug treatments [
 <xref rid="B8-molecules-25-03781" ref-type="bibr">8</xref>]. Nonetheless, the propensity of pathogens to generate resistance motivates the ongoing search for novel therapeutic drugs to combat this dreadful pathogen. Natural products from medicinal plants have played a vital role in the treatment of trypanosomiasis in various African countries [
 <xref rid="B2-molecules-25-03781" ref-type="bibr">2</xref>]. Therefore, medicinal plants have a great potential to provide new antiprotozoal treatments.
</p>
